This revised application is in response to the Mentored Patient-Oriented Research Career Development Award (K-23) and requests 4 years of support for formal coursework, hands-on training experiences, and research to improve HIV-risk reduction interventions targeting HIV-positive injection drug users (IDUs). Despite decades of HIV prevention campaigns targeting high-risk populations, including IDUs, and a rapidly expanding research literature on HIV-risk reduction, over 40,000 new HIV infections are reported yearly in the United States. A growing minority of high risk IDUs, including those who are HIV-positive, jeopardize their own health as well as the health of others via continued health-risk behaviors in three interrelated and modifiable ways including drug-related risks, sex-related risks, and non-adherence or sub-optimal adherence to HIV medication regimens. The behavioral factors perpetuating this epidemic are complex and dynamic. Some IDUs may demonstrate consistent risk behavior """"""""across the board"""""""" whereas others may only engage in certain types of risk behaviors while still others may increase risk behaviors in one or more areas in response to improvements in other risk areas (e.g., increasing sex- and/or drug-risk behaviors in response to learning that their viral load has become undetectable). Therefore, there is an urgent need to identify and understand the key components and dynamics that comprise more effective HIV-risk reduction interventions in order to create an intervention with greater potential to impact HIV-risk among HIV-positive IDUs. The primary goal of the proposed research is to reduce the transmission and spread of HIV/AIDS through risk behaviors of HIV-positive IDUs. This goal will be addressed through three specific aims: (1) To conduct a quantitative synthesis (meta-analysis) of the HIV risk reduction literature focused on IDUs to help specify the key components to consider in creating an optimized risk reduction intervention for HIV-positive IDUs, (2) To conduct elicitation research with HIV-positive IDUs and treatment providers to complement findings from the quantitative synthesis, and based on the above findings, (3) To design and pilot test a theory-driven, ecologically valid (community friendly), risk reduction intervention to significantly reduce HIV-risk behaviors among HIV-positive IDUs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23DA017015-02
Application #
6804727
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Lambert, Elizabeth
Project Start
2003-09-26
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
2
Fiscal Year
2004
Total Cost
$134,198
Indirect Cost
Name
University of Connecticut
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
614209054
City
Storrs-Mansfield
State
CT
Country
United States
Zip Code
06269
Copenhaver, Michael; Shrestha, Roman; Wickersham, Jeffrey A et al. (2016) An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy. J Subst Abuse Treat 63:61-5
Ezeabogu, Ifeoma; Copenhaver, Michael M; Potrepka, Jessica (2012) The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care 24:386-93
Copenhaver, Michael M; Tunku, Noor; Ezeabogu, Ifeoma et al. (2011) Adapting an Evidence-Based Intervention Targeting HIV-Infected Prisoners in Malaysia. AIDS Res Treat 2011:131045
Copenhaver, Michael M; Lee, I-Ching; Margolin, Arthur et al. (2011) Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users. Subst Abus 32:16-26
Copenhaver, Michael; Lee, I-Ching; Merz-Beyus, Amanda et al. (2010) The living arrangement may differentially influence IDU parents' motivation to reduce HIV risk as a function of gender. AIDS Care 22:1373-8
Anand, Pria; Springer, Sandra A; Copenhaver, Michael M et al. (2010) Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav 14:1213-26
Copenhaver, Michael M; Bruce, R Douglas; Altice, Frederick L (2007) Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence. Am J Drug Alcohol Abuse 33:643-54
Copenhaver, Michael M; Lee, I-Ching (2007) Examining the decay of HIV risk reduction outcomes following a community-friendly intervention targeting injection drug users in treatment. J Psychoactive Drugs 39:223-9
Copenhaver, Michael M; Lee, I-Ching; Margolin, Arthur (2007) Successfully integrating an HIV risk reduction intervention into a community-based substance abuse treatment program. Am J Drug Alcohol Abuse 33:109-20
Copenhaver, Michael M; Fisher, Jeffrey D (2006) Experts outline ways to decrease the decade-long yearly rate of 40,000 new HIV infections in the US. AIDS Behav 10:105-14

Showing the most recent 10 out of 11 publications